Report: Suitors found for Sequoia and Actis' Paras

Morgan Stanley has reportedly found five potential trade buyers for the firms' 70% stake in Paras Pharmaceuticals, which is valued at $700m.

5 January 2013•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals Western Europe